Quarterly results
2022 First quarter
We announced our Q1 2022 results on Wednesday 27 April.
Emma Walmsley, GSK CEO, announces our Q1 2022 results
-
2016 Full year and fourth quarter
Watch Sir Andrew Witty, CEO, and Simon Dingemans, CFO discuss our full year 2016 results. Watch Patrick Vallance, President, Pharmaceuticals R&D, give an update on R&D.
Related downloads
- Q4 2016 results announcement PDF - 1.8MB
- Q4 2016 analyst slide presentation PDF - 606.8KB
- Q4 2016 results transcript PDF - 76.6KB
- Q4 2016 results highlights infographic PDF - 895.6KB
- Q4 2016 US dollar translation PDF - 128.4KB
- Q4 2016 actual growth schedules PDF - 132.2KB
- Q4 2016 pre announcement aide memoire PDF - 1,020.8KB
-
2016 Third quarter
Watch Sir Andrew Witty, CEO, and Simon Dingemans, CFO, GSK, discuss our third quarter results 2016.
-
2016 Second quarter
Watch Sir Andrew Witty, CEO, and Simon Dingemans, CFO discuss our second quarter 2016 results. Watch Patrick Vallance, President, Pharmaceuticals R&D, give an update on R&D.
-
2016 First quarter
Watch Sir Andrew Witty, CEO, and Simon Dingemans, CFO, discuss our first quarter 2016 results.
Other key information
-
Speeches & presentations
Search through our archive of speeches and presentations from conferences and events
-
Press releases
Keep up to date with our news and recent announcements
-
GSK Leadership Team
The GSK Leadership Team manages our activities, and each member is responsible for a specific part of the business
-
Our pipeline
We invest in scientific and technical excellence to develop and launch a pipeline of new products that meet the needs of patients and payers
